Order Article Reprints

Na J-E, Park Y-E, Park J-H, Kim T-O, Lee J-Y, Lee J-H, Park S-B, Lee S-B, Hong S-M. Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study. Journal of Personalized Medicine. 2024; 14(10):1066. https://doi.org/10.3390/jpm14101066

Na, Ji-Eun, Yong-Eun Park, Jong-Ha Park, Tae-Oh Kim, Jong-Yoon Lee, Jong-Hoon Lee, Su-Bum Park, Seung-Bum Lee, and Seung-Min Hong. 2024. "Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study" Journal of Personalized Medicine 14, no. 10: 1066. https://doi.org/10.3390/jpm14101066

Na, J.-E., Park, Y.-E., Park, J.-H., Kim, T.-O., Lee, J.-Y., Lee, J.-H., Park, S.-B., Lee, S.-B., & Hong, S.-M. (2024). Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study. Journal of Personalized Medicine, 14(10), 1066. https://doi.org/10.3390/jpm14101066